Department of Cardiac Surgery, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Physiol Res. 2024 Aug 31;73(4):529-541. doi: 10.33549/physiolres.935307.
While 3-N-butylphthalide (NBP) has demonstrated notable cardioprotective effects, its precise role in mitigating myocardial arrhythmia following ischemia/reperfusion (IR) injury in diabetes remains unclear. This study aimed to explore the potential mechanisms through which NBP mitigates reperfusion-induced myocardial arrhythmia in diabetic rats, with a particular focus on mitochondrial function and biogenesis, endoplasmic reticulum (ER) stress, and oxidative/inflammatory responses. Sixty Sprague-Dawley rats were divided into non-diabetic and diabetic groups, subjected to in-vivo myocardial IR injury, and treated with NBP (100 mg/kg, intraperitoneally) through different modalities: preconditioning, postconditioning, or a combination of both. Electrocardiography (ECG) was employed to assess the incidence and severity of arrhythmia. Fluorometric, Western blotting and ELISA analyses were utilized to measure the mitochondrial, ER stress, and cellular outcomes. Treatment of non-diabetic rats with NBP in preconditioned, postconditioned, and combined approaches significantly reduced cardiotroponin-I and the frequency and severity of arrhythmias induced by IR injury. However, only the combined preconditioning plus postconditioning approach of NBP had protective and antiarrhythmic effects in diabetic rats, in an additive manner. Moreover, the NBP combined approach improved mitochondrial function and upregulated the expression of PGC-1?, Sirt1, and glutathione while concurrently downregulating ER stress and oxidative and pro-inflammatory-related proteins in diabetic rats. In conclusion, the combined approach of NBP treatment was effective in mitigating myocardial arrhythmia in diabetic rats. This approach coordinates interactions within the mitochondria-endoplasmic reticulum network and inhibits oxidative and inflammatory mediators, offering a promising strategy for managing myocardial arrhythmia in diabetic patients. Key words: Myocardial Infarction, Mitochondria, Arrhythmia, Reperfusion, Diabetes, Ischemia.
虽然 3-N-正丁基邻苯二甲酸酯(NBP)已显示出显著的心脏保护作用,但它在减轻糖尿病患者缺血/再灌注(IR)损伤后心肌心律失常的确切作用仍不清楚。本研究旨在探讨 NBP 减轻糖尿病大鼠再灌注诱导性心肌心律失常的潜在机制,特别是关注线粒体功能和生物发生、内质网(ER)应激和氧化/炎症反应。将 60 只 Sprague-Dawley 大鼠分为非糖尿病组和糖尿病组,进行体内心肌 IR 损伤,并通过不同方式用 NBP(100mg/kg,腹腔内注射)进行治疗:预处理、后处理或两者结合。心电图(ECG)用于评估心律失常的发生率和严重程度。荧光、Western blot 和 ELISA 分析用于测量线粒体、ER 应激和细胞结果。在预处理、后处理和联合方式下,用 NBP 处理非糖尿病大鼠可显著降低肌钙蛋白 I 和 IR 损伤诱导的心律失常的频率和严重程度。然而,只有 NBP 的联合预处理加后处理方式对糖尿病大鼠具有保护和抗心律失常作用,具有累加效应。此外,NBP 联合方式改善了线粒体功能,上调了 PGC-1?、Sirt1 和谷胱甘肽的表达,同时下调了糖尿病大鼠 ER 应激和氧化及促炎相关蛋白的表达。总之,NBP 联合治疗方法在减轻糖尿病大鼠心肌心律失常方面是有效的。这种方法协调了线粒体-内质网网络内的相互作用,并抑制了氧化和炎症介质,为管理糖尿病患者的心肌心律失常提供了一种有前途的策略。关键词:心肌梗死、线粒体、心律失常、再灌注、糖尿病、缺血。